分子药剂学与有机过程研究杂志

抽象的

HER2-Targeted Antibody Treatment for Ovarian Cancer Future Opportunities

Simon P Langdon, Andrew H Sims

There are an estimated 240,000 new cases of ovarian cancer diagnosed worldwide each year. Due to late presentation, in many parts of the world it remains the most lethal gynecological cancer. In 2004, a new model description of this disease was proposed that combined both histopathological and molecular features and which classified epithelial ovarian cancers into two broad categories designated Type I and Type II tumors.